Bill Text: OH SB57 | 2011-2012 | 129th General Assembly | Introduced

---

Bill Title: To add synthetic cannabinoids commonly known as K2 or Spice to the list of Schedule I controlled substances.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2011-02-01 - To Judiciary Criminal Justice [SB57 Detail]

Download: Ohio-2011-SB57-Introduced.html

---

As Introduced

129th General Assembly Regular Session 2011-2012

S. B. No. 57

Senator Tavares 

---

A BILL

To amend section 3719.41 of the Revised Code to add

1

synthetic cannabinoids commonly known as K2 or

2

Spice to the list of Schedule I controlled

3

substances.

4

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 3719.41 of the Revised Code be	5
amended to read as follows:	6

Sec. 3719.41.  Controlled substance schedules I, II, III, IV,	7
and V are hereby established, which schedules include the	8
following, subject to amendment pursuant to section 3719.43 or	9
3719.44 of the Revised Code.	10

SCHEDULE I	11

(A) Narcotics-opiates

12

Any of the following opiates, including their isomers,	13
esters, ethers, salts, and salts of isomers, esters, and ethers,	14
unless specifically excepted under federal drug abuse control	15
laws, whenever the existence of these isomers, esters, ethers, and	16
salts is possible within the specific chemical designation:	17

(1) Acetyl-alpha-methylfentanyl	18
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);	19

(2) Acetylmethadol;

20

(3) Allylprodine;

21

(4) Alphacetylmethadol (except levo-alphacetylmethadol, also	22
known as levo-alpha-acetylmethadol, levomethadyl acetate, or	23
LAAM);	24

(5) Alphameprodine;

25

(6) Alphamethadol;

26

(7) Alpha-methylfentanyl	27
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;	28
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);	29

(8) Alpha-methylthiofentanyl	30
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-	31
phenylpropanamide);	32

(9) Benzethidine;

33

(10) Betacetylmethadol;

34

(11) Beta-hydroxyfentanyl	35
(N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-N- phenylpropanamide);	36

(12) Beta-hydroxy-3-methylfentanyl (other name:	37
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-	38
phenylpropanamide);	39

(13) Betameprodine;

40

(14) Betamethadol;

41

(15) Betaprodine;

42

(16) Clonitazene;

43

(17) Dextromoramide;

44

(18) Diampromide;

45

(19) Diethylthiambutene;

46

(20) Difenoxin;

47

(21) Dimenoxadol;

48

(22) Dimepheptanol;

49

(23) Dimethylthiambutene;

50

(24) Dioxaphetyl butyrate;

51

(25) Dipipanone;

52

(26) Ethylmethylthiambutene;

53

(27) Etonitazene;

54

(28) Etoxeridine;

55

(29) Furethidine;

56

(30) Hydroxypethidine;

57

(31) Ketobemidone;

58

(32) Levomoramide;

59

(33) Levophenacylmorphan;

60

(34) 3-methylfentanyl	61
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N- phenylpropanamide);	62

(35) 3-methylthiofentanyl	63
(N-[3-methyl-1-[2-(thienyl)ethyl]-4-piperidinyl]-N-	64
phenylpropanamide);	65

(36) Morpheridine;

66

(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

67

(38) Noracymethadol;

68

(39) Norlevorphanol;

69

(40) Normethadone;

70

(41) Norpipanone;

71

(42) Para-fluorofentanyl	72
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide;	73

(43) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;

74

(44) Phenadoxone;

75

(45) Phenampromide;

76

(46) Phenomorphan;

77

(47) Phenoperidine;

78

(48) Piritramide;

79

(49) Proheptazine;

80

(50) Properidine;

81

(51) Propiram;

82

(52) Racemoramide;

83

(53) Thiofentanyl	84
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide;	85

(54) Tilidine;

86

(55) Trimeperidine.

87

(B) Narcotics-opium derivatives

88

Any of the following opium derivatives, including their	89
salts, isomers, and salts of isomers, unless specifically excepted	90
under federal drug abuse control laws, whenever the existence of	91
these salts, isomers, and salts of isomers is possible within the	92
specific chemical designation:	93

(1) Acetorphine;

94

(2) Acetyldihydrocodeine;

95

(3) Benzylmorphine;

96

(4) Codeine methylbromide;

97

(5) Codeine-n-oxide;

98

(6) Cyprenorphine;

99

(7) Desomorphine;

100

(8) Dihydromorphine;

101

(9) Drotebanol;

102

(10) Etorphine (except hydrochloride salt);

103

(11) Heroin;

104

(12) Hydromorphinol;

105

(13) Methyldesorphine;

106

(14) Methyldihydromorphine;

107

(15) Morphine methylbromide;

108

(16) Morphine methylsulfonate;

109

(17) Morphine-n-oxide;

110

(18) Myrophine;

111

(19) Nicocodeine;

112

(20) Nicomorphine;

113

(21) Normorphine;

114

(22) Pholcodine;

115

(23) Thebacon.

116

(C) Hallucinogens

117

Any material, compound, mixture, or preparation that contains	118
any quantity of the following hallucinogenic substances, including	119
their salts, isomers, and salts of isomers, unless specifically	120
excepted under federal drug abuse control laws, whenever the	121
existence of these salts, isomers, and salts of isomers is	122
possible within the specific chemical designation. For the	123
purposes of this division only, "isomer" includes the optical	124
isomers, position isomers, and geometric isomers.	125

(1) Alpha-ethyltryptamine (some trade or other names:	126
etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine;	127
3-(2-aminobutyl) indole; alpha-ET; and AET);	128

(2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other	129
names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine;	130
4-bromo-2,5-DMA);	131

(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or other	132
names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;	133
alpha-desmethyl DOB; 2C-B, Nexus);	134

(4) 2,5-dimethoxyamphetamine (some trade or other names:	135
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);	136

(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other	137
names: DOET);	138

(6) 4-methoxyamphetamine (some trade or other names:	139
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;	140
PMA);	141

(7) 5-methoxy-3,4-methylenedioxy-amphetamine;

142

(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or other	143
names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"	144
and "STP");	145

(9) 3,4-methylenedioxy amphetamine;

146

(10) 3,4-methylenedioxymethamphetamine (MDMA);

147

(11) 3,4-methylenedioxy-N-ethylamphetamine (also known as	148
N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl	149
MDA, MDE, MDEA);	150

(12) N-hydroxy-3,4-methylenedioxyamphetamine (also known as	151
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and	152
N-hydroxy MDA);	153

(13) 3,4,5-trimethoxy amphetamine;

154

(14) Bufotenine (some trade or other names:	155
3-(beta-dimethylaminoethyl)-5-hydroxyindole;	156
3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin;	157
5-hydroxy-N, N-dimethyltryptamine; mappine);	158

(15) Diethyltryptamine (some trade or other names: N,	159
N-diethyltryptamine; DET);	160

(16) Dimethyltryptamine (some trade or other names: DMT);

161

(17) Ibogaine (some trade or other names:	162
7-ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-	163
5H-pyrido[1',2':1,2] azepino [5, 4-b] indole; tabernanthe iboga);	164

(18) Lysergic acid diethylamide;

165

(19) Marihuana;

166

(20) Mescaline;

167

(21) Parahexyl (some trade or other names: 3-hexyl-1-	168
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;	169
synhexyl);	170

(22) Peyote (meaning all parts of the plant presently	171
classified botanically as "Lophophora williamsii Lemaire," whether	172
growing or not, the seeds of that plant, any extract from any part	173
of that plant, and every compound, manufacture, salts, derivative,	174
mixture, or preparation of that plant, its seeds, or its	175
extracts);	176

(23) N-ethyl-3-piperidyl benzilate;

177

(24) N-methyl-3-piperidyl benzilate;

178

(25) Psilocybin;

179

(26) Psilocyn;

180

(27) Tetrahydrocannabinols (synthetic equivalents of the	181
substances contained in the plant, or in the resinous extractives	182
of Cannabis, sp. and/or synthetic substances, derivatives, and	183
their isomers with similar chemical structure and pharmacological	184
activity such as the following: delta-1-cis or trans	185
tetrahydrocannabinol, and their optical isomers; delta-6-cis or	186
trans tetrahydrocannabinol, and their optical isomers;	187
delta-3,4-cis or trans tetrahydrocannabinol, and its optical	188
isomers. (Since nomenclature of these substances is not	189
internationally standardized, compounds of these structures,	190
regardless of numerical designation of atomic positions, are	191
covered.));	192

(28) Ethylamine analog of phencyclidine (some trade or other	193
names: N-ethyl-1-phenylcyclohexylamine;	194
(1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;	195
cyclohexamine; PCE);	196

(29) Pyrrolidine analog of phencyclidine (some trade or other	197
names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPy; PHP);	198

(30) Thiophene analog of phencyclidine (some trade or other	199
names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog	200
of phencyclidine; TPCP; TCP);	201

(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine;

202

(32) Hashish;

203

(33) Salvia divinorum;

204

(34) Salvinorin A;

205

(35) 1-pentyl-3-(1-naphthoyl) indole (some trade or other	206
names: JWH-018);	207

(36) 1-butyl-3-(1-naphthoyl) indole (some trade or other	208
names: JWH-073).	209

(D) Depressants

210

Any material, compound, mixture, or preparation that contains	211
any quantity of the following substances having a depressant	212
effect on the central nervous system, including their salts,	213
isomers, and salts of isomers, unless specifically excepted under	214
federal drug abuse control laws, whenever the existence of these	215
salts, isomers, and salts of isomers is possible within the	216
specific chemical designation:	217

(1) Mecloqualone;

218

(2) Methaqualone.

219

(E) Stimulants

220

Unless specifically excepted or unless listed in another	221
schedule, any material, compound, mixture, or preparation that	222
contains any quantity of the following substances having a	223
stimulant effect on the central nervous system, including their	224
salts, isomers, and salts of isomers:	225

(1) Aminorex (some other names: aminoxaphen;	226
2-amino-5-phenyl-2-oxazoline; or	227
4,5-dihydro-5-phenyl-2-oxazolamine);	228

(2) Cathinone (some trade or other names:	229
2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,	230
2-aminopropiophenone, and norephedrone);	231

(3) Fenethylline;

232

(4) Methcathinone (some other names:	233
2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone;	234
2-methylamino)-1-phenylpropan-1-one;	235
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;	236
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and	237
UR1432, its salts, optical isomers, and salts of optical isomers;	238

(5) (+/-)cis-4-methylaminorex	239
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);	240

(6) N-ethylamphetamine;

241

(7) N,N-dimethylamphetamine (also known as	242
N,N-alpha-trimethyl-benzeneethanamine;	243
N,N-alpha-trimethylphenethylamine).	244

SCHEDULE II	245

(A) Narcotics-opium and opium derivatives

246

Unless specifically excepted under federal drug abuse control	247
laws or unless listed in another schedule, any of the following	248
substances whether produced directly or indirectly by extraction	249
from substances of vegetable origin, independently by means of	250
chemical synthesis, or by a combination of extraction and chemical	251
synthesis:	252

(1) Opium and opiate, and any salt, compound, derivative, or	253
preparation of opium or opiate, excluding apomorphine,	254
thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene,	255
naloxone, and naltrexone, and their respective salts, but	256
including the following:	257

(a) Raw opium;

258

(b) Opium extracts;

259

(c) Opium fluid extracts;

260

(d) Powdered opium;

261

(e) Granulated opium;

262

(f) Tincture of opium;

263

(g) Codeine;

264

(h) Ethylmorphine;

265

(i) Etorphine hydrochloride;

266

(j) Hydrocodone;

267

(k) Hydromorphone;

268

(l) Metopon;

269

(m) Morphine;

270

(n) Oxycodone;

271

(o) Oxymorphone;

272

(p) Thebaine.

273

(2) Any salt, compound, derivative, or preparation thereof	274
that is chemically equivalent to or identical with any of the	275
substances referred to in division (A)(1) of this schedule, except	276
that these substances shall not include the isoquinoline alkaloids	277
of opium;	278

(3) Opium poppy and poppy straw;

279

(4) Coca leaves and any salt, compound, derivative, or	280
preparation of coca leaves (including cocaine and ecgonine, their	281
salts, isomers, and derivatives, and salts of those isomers and	282
derivatives), and any salt, compound, derivative, or preparation	283
thereof that is chemically equivalent to or identical with any of	284
these substances, except that the substances shall not include	285
decocainized coca leaves or extraction of coca leaves, which	286
extractions do not contain cocaine or ecgonine;	287

(5) Concentrate of poppy straw (the crude extract of poppy	288
straw in either liquid, solid, or powder form that contains the	289
phenanthrene alkaloids of the opium poppy).	290

(B) Narcotics-opiates

291

Unless specifically excepted under federal drug abuse control	292
laws or unless listed in another schedule, any of the following	293
opiates, including their isomers, esters, ethers, salts, and salts	294
of isomers, esters, and ethers, whenever the existence of these	295
isomers, esters, ethers, and salts is possible within the specific	296
chemical designation, but excluding dextrorphan and	297
levopropoxyphene:	298

(1) Alfentanil;

299

(2) Alphaprodine;

300

(3) Anileridine;

301

(4) Bezitramide;

302

(5) Bulk dextropropoxyphene (non-dosage forms);

303

(6) Carfentanil;

304

(7) Dihydrocodeine;

305

(8) Diphenoxylate;

306

(9) Fentanyl;

307

(10) Isomethadone;

308

(11) Levo-alphacetylmethadol (some other names:	309
levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);	310

(12) Levomethorphan;

311

(13) Levorphanol;

312

(14) Metazocine;

313

(15) Methadone;

314

(16) Methadone-intermediate,	315
4-cyano-2-dimethylamino-4,4-diphenyl butane;	316

(17) Moramide-intermediate,	317
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;	318

(18) Pethidine (meperidine);

319

(19) Pethidine-intermediate-A,	320
4-cyano-1-methyl-4-phenylpiperidine;	321

(20) Pethidine-intermediate-B,	322
ethyl-4-phenylpiperidine-4-carboxylate;	323

(21) Pethidine-intermediate-C,	324
1-methyl-4-phenylpiperidine-4-carboxylic acid;	325

(22) Phenazocine;

326

(23) Piminodine;

327

(24) Racemethorphan;

328

(25) Racemorphan;

329

(26) Remifentanil;

330

(27) Sufentanil.

331

(C) Stimulants

332

Unless specifically excepted under federal drug abuse control	333
laws or unless listed in another schedule, any material, compound,	334
mixture, or preparation that contains any quantity of the	335
following substances having a stimulant effect on the central	336
nervous system:	337

(1) Amphetamine, its salts, its optical isomers, and salts of	338
its optical isomers;	339

(2) Methamphetamine, its salts, its isomers, and salts of its	340
isomers;	341

(3) Methylphenidate;

342

(4) Phenmetrazine and its salts.

343

(D) Depressants

344

Unless specifically excepted under federal drug abuse control	345
laws or unless listed in another schedule, any material, compound,	346
mixture, or preparation that contains any quantity of the	347
following substances having a depressant effect on the central	348
nervous system, including their salts, isomers, and salts of	349
isomers, whenever the existence of these salts, isomers, and salts	350
of isomers is possible within the specific chemical designation:	351

(1) Amobarbital;

352

(2) Gamma-hydroxy-butyrate;

353

(3) Glutethimide;

354

(4) Pentobarbital;

355

(5) Phencyclidine (some trade or other names:	356
1-(1-phenylcyclohexyl)piperidine; PCP);	357

(6) Secobarbital;

358

(7) 1-aminophenylcyclohexane and all N-mono-substituted	359
and/or all N-N-disubstituted analogs including, but not limited	360
to, the following:	361

(a) 1-phenylcyclohexylamine;

362

(b) (1-phenylcyclohexyl) methylamine;

363

(c) (1-phenylcyclohexyl) dimethylamine;

364

(d) (1-phenylcyclohexyl) methylethylamine;

365

(e) (1-phenylcyclohexyl) isopropylamine;

366

(f) 1-(1-phenylcyclohexyl) morpholine.

367

(E) Hallucinogenic substances

368

(1) Nabilone (another name for nabilone:	369
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-	370
hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one).	371

(F) Immediate precursors

372

Unless specifically excepted under federal drug abuse control	373
laws or unless listed in another schedule, any material, compound,	374
mixture, or preparation that contains any quantity of the	375
following substances:	376

(1) Immediate precursor to amphetamine and methamphetamine:

377

(a) Phenylacetone (some trade or other names:	378
phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl	379
ketone);	380

(2) Immediate precursors to phencyclidine (PCP):

381

(a) 1-phenylcyclohexylamine;

382

(b) 1-piperidinocyclohexanecarbonitrile (PCC).

383

SCHEDULE III	384

(A) Stimulants

385

Unless specifically excepted under federal drug abuse control	386
laws or unless listed in another schedule, any material, compound,	387
mixture, or preparation that contains any quantity of the	388
following substances having a stimulant effect on the central	389
nervous system, including their salts, their optical isomers,	390
position isomers, or geometric isomers, and salts of these	391
isomers, whenever the existence of these salts, isomers, and salts	392
of isomers is possible within the specific chemical designation:	393

(1) All stimulant compounds, mixtures, and preparations	394
included in schedule III pursuant to the federal drug abuse	395
control laws and regulations adopted under those laws;	396

(2) Benzphetamine;

397

(3) Chlorphentermine;

398

(4) Clortermine;

399

(5) Phendimetrazine.

400

(B) Depressants

401

Unless specifically excepted under federal drug abuse control	402
laws or unless listed in another schedule, any material, compound,	403
mixture, or preparation that contains any quantity of the	404
following substances having a depressant effect on the central	405
nervous system:	406

(1) Any compound, mixture, or preparation containing	407
amobarbital, secobarbital, pentobarbital, or any salt of any of	408
these drugs, and one or more other active medicinal ingredients	409
that are not listed in any schedule;	410

(2) Any suppository dosage form containing amobarbital,	411
secobarbital, pentobarbital, or any salt of any of these drugs and	412
approved by the food and drug administration for marketing only as	413
a suppository;	414

(3) Any substance that contains any quantity of a derivative	415
of barbituric acid or any salt of a derivative of barbituric acid;	416

(4) Chlorhexadol;

417

(5) Ketamine, its salts, isomers, and salts of isomers (some	418
other names for ketamine:	419
(+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone);	420

(6) Lysergic acid;

421

(7) Lysergic acid amide;

422

(8) Methyprylon;

423

(9) Sulfondiethylmethane;

424

(10) Sulfonethylmethane;

425

(11) Sulfonmethane;

426

(12) Tiletamine, zolazepam, or any salt of tiletamine or	427
zolazepam (some trade or other names for a tiletamine-zolazepam	428
combination product: Telazol); (some trade or other names for	429
tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some	430
trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-	431
dihydro-1,3,8-trimethylpyrazolo-[3, 4-e][1,4]-diazepin-7(1H)-one;	432
flupyrazapon).	433

(C) Narcotic antidotes

434

(1) Nalorphine.

435

(D) Narcotics-narcotic preparations

436

Unless specifically excepted under federal drug abuse control	437
laws or unless listed in another schedule, any material, compound,	438
mixture, or preparation that contains any of the following	439
narcotic drugs, or their salts calculated as the free anhydrous	440
base or alkaloid, in limited quantities as set forth below:	441

(1) Not more than 1.8 grams of codeine per 100 milliliters or	442
not more than 90 milligrams per dosage unit, with an equal or	443
greater quantity of an isoquinoline alkaloid of opium;	444

(2) Not more than 1.8 grams of codeine per 100 milliliters or	445
not more than 90 milligrams per dosage unit, with one or more	446
active, nonnarcotic ingredients in recognized therapeutic amounts;	447

(3) Not more than 300 milligrams of dihydrocodeinone per 100	448
milliliters or not more than 15 milligrams per dosage unit, with a	449
fourfold or greater quantity of an isoquinoline alkaloid of opium;	450

(4) Not more than 300 milligrams of dihydrocodeinone per 100	451
milliliters or not more than 15 milligrams per dosage unit, with	452
one or more active, nonnarcotic ingredients in recognized	453
therapeutic amounts;	454

(5) Not more than 1.8 grams of dihydrocodeine per 100	455
milliliters or not more than 90 milligrams per dosage unit, with	456
one or more active, nonnarcotic ingredients in recognized	457
therapeutic amounts;	458

(6) Not more than 300 milligrams of ethylmorphine per 100	459
milliliters or not more than 15 milligrams per dosage unit, with	460
one or more active, nonnarcotic ingredients in recognized	461
therapeutic amounts;	462

(7) Not more than 500 milligrams of opium per 100 milliliters	463
or per 100 grams or not more than 25 milligrams per dosage unit,	464
with one or more active, nonnarcotic ingredients in recognized	465
therapeutic amounts;	466

(8) Not more than 50 milligrams of morphine per 100	467
milliliters or per 100 grams, with one or more active, nonnarcotic	468
ingredients in recognized therapeutic amounts.	469

(E) Anabolic steroids

470

Unless specifically excepted under federal drug abuse control	471
laws or unless listed in another schedule, any material, compound,	472
mixture, or preparation that contains any quantity of the	473
following substances, including their salts, esters, isomers, and	474
salts of esters and isomers, whenever the existence of these	475
salts, esters, and isomers is possible within the specific	476
chemical designation:	477

(1) Anabolic steroids. Except as otherwise provided in	478
division (E)(1) of schedule III, "anabolic steroids" means any	479
drug or hormonal substance that is chemically and	480
pharmacologically related to testosterone (other than estrogens,	481
progestins, and corticosteroids) and that promotes muscle growth.	482
"Anabolic steroids" does not include an anabolic steroid that is	483
expressly intended for administration through implants to cattle	484
or other nonhuman species and that has been approved by the United	485
States secretary of health and human services for that	486
administration, unless a person prescribes, dispenses, or	487
distributes this type of anabolic steroid for human use. "Anabolic	488
steroid" includes, but is not limited to, the following:	489

(a) Boldenone;

490

(b) Chlorotestosterone (4-chlortestosterone);

491

(c) Clostebol;

492

(d) Dehydrochlormethyltestosterone;

493

(e) Dihydrotestosterone (4-dihydrotestosterone);

494

(f) Drostanolone;

495

(g) Ethylestrenol;

496

(h) Fluoxymesterone;

497

(i) Formebulone (formebolone);

498

(j) Mesterolone;

499

(k) Methandienone;

500

(l) Methandranone;

501

(m) Methandriol;

502

(n) Methandrostenolone;

503

(o) Methenolone;

504

(p) Methyltestosterone;

505

(q) Mibolerone;

506

(r) Nandrolone;

507

(s) Norethandrolone;

508

(t) Oxandrolone;

509

(u) Oxymesterone;

510

(v) Oxymetholone;

511

(w) Stanolone;

512

(x) Stanozolol;

513

(y) Testolactone;

514

(z) Testosterone;

515

(aa) Trenbolone;

516

(bb) Any salt, ester, isomer, or salt of an ester or isomer	517
of a drug or hormonal substance described or listed in division	518
(E)(1) of schedule III if the salt, ester, or isomer promotes	519
muscle growth.	520

(F) Hallucinogenic substances

521

(1) Dronabinol (synthetic) in sesame oil and encapsulated in	522
a soft gelatin capsule in a United States food and drug	523
administration approved drug product (some other names for	524
dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-	525
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or	526
(-)-delta-9-(trans)-tetrahydrocannabinol).	527

SCHEDULE IV	528

(A) Narcotic drugs

529

Unless specifically excepted by federal drug abuse control	530
laws or unless listed in another schedule, any material, compound,	531
mixture, or preparation that contains any of the following	532
narcotic drugs, or their salts calculated as the free anhydrous	533
base or alkaloid, in limited quantities as set forth below:	534

(1) Not more than one milligram of difenoxin and not less	535
than 25 micrograms of atropine sulfate per dosage unit;	536

(2) Dextropropoxyphene	537
(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-	538
propionoxybutane)[final dosage forms].	539

(B) Depressants

540

Unless specifically excepted under federal drug abuse control	541
laws or unless listed in another schedule, any material, compound,	542
mixture, or preparation that contains any quantity of the	543
following substances, including their salts, isomers, and salts of	544
isomers, whenever the existence of these salts, isomers, and salts	545
of isomers is possible within the specific chemical designation:	546

(1) Alprazolam;

547

(2) Barbital;

548

(3) Bromazepam;

549

(4) Camazepam;

550

(5) Chloral betaine;

551

(6) Chloral hydrate;

552

(7) Chlordiazepoxide;

553

(8) Clobazam;

554

(9) Clonazepam;

555

(10) Clorazepate;

556

(11) Clotiazepam;

557

(12) Cloxazolam;

558

(13) Delorazepam;

559

(14) Diazepam;

560

(15) Estazolam;

561

(16) Ethchlorvynol;

562

(17) Ethinamate;

563

(18) Ethyl loflazepate;

564

(19) Fludiazepam;

565

(20) Flunitrazepam;

566

(21) Flurazepam;

567

(22) Halazepam;

568

(23) Haloxazolam;

569

(24) Ketazolam;

570

(25) Loprazolam;

571

(26) Lorazepam;

572

(27) Lormetazepam;

573

(28) Mebutamate;

574

(29) Medazepam;

575

(30) Meprobamate;

576

(31) Methohexital;

577

(32) Methylphenobarbital (mephobarbital);

578

(33) Midazolam;

579

(34) Nimetazepam;

580

(35) Nitrazepam;

581

(36) Nordiazepam;

582

(37) Oxazepam;

583

(38) Oxazolam;

584

(39) Paraldehyde;

585

(40) Petrichloral;

586

(41) Phenobarbital;

587

(42) Pinazepam;

588

(43) Prazepam;

589

(44) Quazepam;

590

(45) Temazepam;

591

(46) Tetrazepam;

592

(47) Triazolam;

593

(48) Zaleplon;

594

(49) Zolpidem.

595

(C) Fenfluramine

596

Any material, compound, mixture, or preparation that contains	597
any quantity of the following substances, including their salts,	598
their optical isomers, position isomers, or geometric isomers, and	599
salts of these isomers, whenever the existence of these salts,	600
isomers, and salts of isomers is possible within the specific	601
chemical designation:	602

(1) Fenfluramine.

603

(D) Stimulants

604

Unless specifically excepted under federal drug abuse control	605
laws or unless listed in another schedule, any material, compound,	606
mixture, or preparation that contains any quantity of the	607
following substances having a stimulant effect on the central	608
nervous system, including their salts, their optical isomers,	609
position isomers, or geometric isomers, and salts of these	610
isomers, whenever the existence of these salts, isomers, and salts	611
of isomers is possible within the specific chemical designation:	612

(1) Cathine ((+)-norpseudoephedrine);

613

(2) Diethylpropion;

614

(3) Fencamfamin;

615

(4) Fenproporex;

616

(5) Mazindol;

617

(6) Mefenorex;

618

(7) Modafinil;

619

(8) Pemoline (including organometallic complexes and chelates	620
thereof);	621

(9) Phentermine;

622

(10) Pipradrol;

623

(11) Sibutramine;

624

(12) SPA [(-)-1-dimethylamino-1,2-diphenylethane].

625

(E) Other substances

626

Unless specifically excepted under federal drug abuse control	627
laws or unless listed in another schedule, any material, compound,	628
mixture, or preparation that contains any quantity of the	629
following substances, including their salts:	630

(1) Pentazocine;

631

(2) Butorphanol (including its optical isomers).

632

SCHEDULE V	633

(A) Narcotic drugs

634

Unless specifically excepted under federal drug abuse control	635
laws or unless listed in another schedule, any material, compound,	636
mixture, or preparation that contains any of the following	637
narcotic drugs, and their salts, as set forth below:	638

(1) Buprenorphine.

639

(B) Narcotics-narcotic preparations

640

Narcotic drugs containing non-narcotic active medicinal	641
ingredients. Any compound, mixture, or preparation that contains	642
any of the following narcotic drugs, or their salts calculated as	643
the free anhydrous base or alkaloid, in limited quantities as set	644
forth below, and that includes one or more nonnarcotic active	645
medicinal ingredients in sufficient proportion to confer upon the	646
compound, mixture, or preparation valuable medicinal qualities	647
other than those possessed by narcotic drugs alone:	648

(1) Not more than 200 milligrams of codeine per 100	649
milliliters or per 100 grams;	650

(2) Not more than 100 milligrams of dihydrocodeine per 100	651
milliliters or per 100 grams;	652

(3) Not more than 100 milligrams of ethylmorphine per 100	653
milliliters or per 100 grams;	654

(4) Not more than 2.5 milligrams of diphenoxylate and not	655
less than 25 micrograms of atropine sulfate per dosage unit;	656

(5) Not more than 100 milligrams of opium per 100 milliliters	657
or per 100 grams;	658

(6) Not more than 0.5 milligram of difenoxin and not less	659
than 25 micrograms of atropine sulfate per dosage unit.	660

(C) Stimulants

661

Unless specifically exempted or excluded under federal drug	662
abuse control laws or unless listed in another schedule, any	663
material, compound, mixture, or preparation that contains any	664
quantity of the following substances having a stimulant effect on	665
the central nervous system, including their salts, isomers, and	666
salts of isomers:	667

(1) Ephedrine, except as provided in division (K) of section	668
3719.44 of the Revised Code;	669

(2) Pyrovalerone.

670

Section 2. That existing section 3719.41 of the Revised Code	671
is hereby repealed.	672